Parent, Guarantor, Non-Guarantor Unaudited Consolidating Condensed Financial Statements - Consolidated Condensed Statements of Cash Flows (Detail) - USD ($)
$ in Thousands |
3 Months Ended |
9 Months Ended |
Sep. 30, 2017 |
Sep. 30, 2016 |
Sep. 30, 2017 |
Sep. 30, 2016 |
| Cash flows from operating activities: |
|
|
|
|
| Net income (loss) |
$ (20,311)
|
$ (46,228)
|
$ (90,008)
|
$ (181,885)
|
| Adjustments to reconcile net income (loss) |
|
|
|
|
| Depreciation and amortization |
30,067
|
34,474
|
93,251
|
106,605
|
| Accretion of contingent consideration |
|
|
0
|
419
|
| Provision for reduction in carrying value of certain assets |
|
|
|
1,088
|
| Loss on debt modification |
|
|
0
|
1,088
|
| (Gain) loss on disposition of assets |
(97)
|
187
|
368
|
249
|
| Deferred income tax expense (benefit) |
|
|
(594)
|
61,199
|
| Expenses not requiring cash |
|
|
5,899
|
(3,005)
|
| Equity in net earnings of subsidiaries |
0
|
0
|
0
|
0
|
| Accounts and notes receivable |
|
|
(14,908)
|
44,799
|
| Other assets |
|
|
(325)
|
3,282
|
| Accounts payable and accrued liabilities |
|
|
(18,520)
|
(30,590)
|
| Accrued income taxes |
|
|
431
|
(1,992)
|
| Net cash provided by operating activities |
|
|
(24,406)
|
(1,582)
|
| Cash flows from investing activities: |
|
|
|
|
| Capital expenditures |
|
|
(44,836)
|
(20,994)
|
| Proceeds from the sale of assets |
|
|
322
|
2,296
|
| Net cash used in investing activities |
|
|
(44,514)
|
(18,698)
|
| Cash flows from financing activities: |
|
|
|
|
| Payment for noncontrolling interest |
|
|
0
|
(3,375)
|
| Payments of contingent consideration |
|
|
0
|
(6,000)
|
| Proceeds from Issuance of Common Stock |
|
|
25,200
|
0
|
| Proceeds from Issuance of Preferred Stock and Preference Stock |
|
|
50,000
|
0
|
| Payments of Stock Issuance Costs |
|
|
(2,864)
|
0
|
| Payments of Ordinary Dividends, Preferred Stock and Preference Stock |
|
|
(1,239)
|
0
|
| Payments Related to Tax Withholding for Share-based Compensation |
|
|
(829)
|
(1,026)
|
| Excess tax benefit from stock-based compensation |
|
|
0
|
(1,751)
|
| Intercompany advances, net |
|
|
0
|
0
|
| Net cash used in financing activities |
|
|
70,268
|
(10,401)
|
| Net increase (decrease) in cash and cash equivalents |
|
|
1,348
|
(30,681)
|
| Cash and cash equivalents, beginning of year |
|
|
119,691
|
134,294
|
| Cash and cash equivalents, end of period |
121,039
|
103,613
|
121,039
|
103,613
|
| Parent [Member] |
|
|
|
|
| Cash flows from operating activities: |
|
|
|
|
| Net income (loss) |
(20,311)
|
(46,228)
|
(90,008)
|
(181,885)
|
| Adjustments to reconcile net income (loss) |
|
|
|
|
| Depreciation and amortization |
0
|
0
|
0
|
0
|
| Accretion of contingent consideration |
|
|
|
0
|
| Provision for reduction in carrying value of certain assets |
|
|
|
1,088
|
| (Gain) loss on disposition of assets |
0
|
0
|
0
|
0
|
| Deferred income tax expense (benefit) |
|
|
(14,138)
|
46,773
|
| Expenses not requiring cash |
|
|
4,479
|
5,181
|
| Equity in net earnings of subsidiaries |
8,172
|
24,887
|
45,774
|
65,679
|
| Accounts and notes receivable |
|
|
0
|
0
|
| Other assets |
|
|
(34,318)
|
(113,372)
|
| Accounts payable and accrued liabilities |
|
|
(57,275)
|
(7,079)
|
| Accrued income taxes |
|
|
76,281
|
33,313
|
| Net cash provided by operating activities |
|
|
(69,205)
|
(152,053)
|
| Cash flows from investing activities: |
|
|
|
|
| Capital expenditures |
|
|
0
|
0
|
| Proceeds from the sale of assets |
|
|
0
|
0
|
| Net cash used in investing activities |
|
|
0
|
0
|
| Cash flows from financing activities: |
|
|
|
|
| Payment for noncontrolling interest |
|
|
|
(3,375)
|
| Payments of contingent consideration |
|
|
0
|
|
| Proceeds from Issuance of Common Stock |
|
|
25,200
|
|
| Proceeds from Issuance of Preferred Stock and Preference Stock |
|
|
50,000
|
|
| Payments of Stock Issuance Costs |
|
|
2,864
|
|
| Payments of Ordinary Dividends, Preferred Stock and Preference Stock |
|
|
(1,239)
|
|
| Payments Related to Tax Withholding for Share-based Compensation |
|
|
829
|
(1,026)
|
| Excess tax benefit from stock-based compensation |
|
|
|
(1,751)
|
| Intercompany advances, net |
|
|
0
|
136,511
|
| Net cash used in financing activities |
|
|
70,268
|
132,110
|
| Net increase (decrease) in cash and cash equivalents |
|
|
1,063
|
(19,943)
|
| Cash and cash equivalents, beginning of year |
|
|
65,000
|
73,985
|
| Cash and cash equivalents, end of period |
66,063
|
54,042
|
66,063
|
54,042
|
| Guarantor [Member] |
|
|
|
|
| Cash flows from operating activities: |
|
|
|
|
| Net income (loss) |
(3,996)
|
(18,409)
|
(28,283)
|
(49,224)
|
| Adjustments to reconcile net income (loss) |
|
|
|
|
| Depreciation and amortization |
20,025
|
22,300
|
61,483
|
68,739
|
| Accretion of contingent consideration |
|
|
|
419
|
| Provision for reduction in carrying value of certain assets |
|
|
|
0
|
| (Gain) loss on disposition of assets |
0
|
12
|
242
|
(141)
|
| Deferred income tax expense (benefit) |
|
|
12,217
|
12,693
|
| Expenses not requiring cash |
|
|
(45)
|
(505)
|
| Equity in net earnings of subsidiaries |
0
|
0
|
0
|
0
|
| Accounts and notes receivable |
|
|
(18,515)
|
26,956
|
| Other assets |
|
|
26,426
|
119,703
|
| Accounts payable and accrued liabilities |
|
|
42,116
|
(16,486)
|
| Accrued income taxes |
|
|
(57,261)
|
(27,191)
|
| Net cash provided by operating activities |
|
|
38,380
|
134,963
|
| Cash flows from investing activities: |
|
|
|
|
| Capital expenditures |
|
|
(35,301)
|
(10,121)
|
| Proceeds from the sale of assets |
|
|
26
|
435
|
| Net cash used in investing activities |
|
|
(35,275)
|
(9,686)
|
| Cash flows from financing activities: |
|
|
|
|
| Payment for noncontrolling interest |
|
|
|
0
|
| Payments of contingent consideration |
|
|
(6,000)
|
|
| Proceeds from Issuance of Common Stock |
|
|
0
|
|
| Proceeds from Issuance of Preferred Stock and Preference Stock |
|
|
0
|
|
| Payments of Stock Issuance Costs |
|
|
0
|
|
| Payments of Ordinary Dividends, Preferred Stock and Preference Stock |
|
|
0
|
|
| Payments Related to Tax Withholding for Share-based Compensation |
|
|
0
|
0
|
| Excess tax benefit from stock-based compensation |
|
|
|
0
|
| Intercompany advances, net |
|
|
0
|
(119,447)
|
| Net cash used in financing activities |
|
|
0
|
(125,447)
|
| Net increase (decrease) in cash and cash equivalents |
|
|
3,105
|
(170)
|
| Cash and cash equivalents, beginning of year |
|
|
14,365
|
13,854
|
| Cash and cash equivalents, end of period |
17,470
|
13,684
|
17,470
|
13,684
|
| Non-Guarantor [Member] |
|
|
|
|
| Cash flows from operating activities: |
|
|
|
|
| Net income (loss) |
(4,176)
|
(6,478)
|
(17,491)
|
(16,455)
|
| Adjustments to reconcile net income (loss) |
|
|
|
|
| Depreciation and amortization |
10,042
|
12,174
|
31,768
|
37,866
|
| Accretion of contingent consideration |
|
|
|
0
|
| Provision for reduction in carrying value of certain assets |
|
|
|
0
|
| (Gain) loss on disposition of assets |
(97)
|
175
|
126
|
390
|
| Deferred income tax expense (benefit) |
|
|
1,327
|
1,733
|
| Expenses not requiring cash |
|
|
1,465
|
(7,681)
|
| Equity in net earnings of subsidiaries |
0
|
0
|
0
|
0
|
| Accounts and notes receivable |
|
|
3,607
|
17,843
|
| Other assets |
|
|
7,567
|
(3,049)
|
| Accounts payable and accrued liabilities |
|
|
(3,361)
|
(7,025)
|
| Accrued income taxes |
|
|
(18,589)
|
(8,114)
|
| Net cash provided by operating activities |
|
|
6,419
|
15,508
|
| Cash flows from investing activities: |
|
|
|
|
| Capital expenditures |
|
|
(9,535)
|
(10,873)
|
| Proceeds from the sale of assets |
|
|
296
|
1,861
|
| Net cash used in investing activities |
|
|
(9,239)
|
(9,012)
|
| Cash flows from financing activities: |
|
|
|
|
| Payment for noncontrolling interest |
|
|
|
0
|
| Payments of contingent consideration |
|
|
0
|
|
| Proceeds from Issuance of Common Stock |
|
|
0
|
|
| Proceeds from Issuance of Preferred Stock and Preference Stock |
|
|
0
|
|
| Payments of Stock Issuance Costs |
|
|
0
|
|
| Payments of Ordinary Dividends, Preferred Stock and Preference Stock |
|
|
0
|
|
| Payments Related to Tax Withholding for Share-based Compensation |
|
|
0
|
0
|
| Excess tax benefit from stock-based compensation |
|
|
|
0
|
| Intercompany advances, net |
|
|
0
|
(17,064)
|
| Net cash used in financing activities |
|
|
0
|
(17,064)
|
| Net increase (decrease) in cash and cash equivalents |
|
|
(2,820)
|
(10,568)
|
| Cash and cash equivalents, beginning of year |
|
|
40,326
|
46,455
|
| Cash and cash equivalents, end of period |
37,506
|
35,887
|
37,506
|
35,887
|
| Consolidation, Eliminations [Member] |
|
|
|
|
| Cash flows from operating activities: |
|
|
|
|
| Net income (loss) |
8,172
|
24,887
|
45,774
|
65,679
|
| Adjustments to reconcile net income (loss) |
|
|
|
|
| Depreciation and amortization |
0
|
0
|
0
|
0
|
| Accretion of contingent consideration |
|
|
|
0
|
| Provision for reduction in carrying value of certain assets |
|
|
|
0
|
| (Gain) loss on disposition of assets |
0
|
0
|
0
|
0
|
| Deferred income tax expense (benefit) |
|
|
0
|
0
|
| Expenses not requiring cash |
|
|
0
|
0
|
| Equity in net earnings of subsidiaries |
(8,172)
|
(24,887)
|
(45,774)
|
(65,679)
|
| Accounts and notes receivable |
|
|
0
|
0
|
| Other assets |
|
|
0
|
0
|
| Accounts payable and accrued liabilities |
|
|
0
|
0
|
| Accrued income taxes |
|
|
0
|
0
|
| Net cash provided by operating activities |
|
|
0
|
0
|
| Cash flows from investing activities: |
|
|
|
|
| Capital expenditures |
|
|
0
|
0
|
| Proceeds from the sale of assets |
|
|
0
|
0
|
| Net cash used in investing activities |
|
|
0
|
0
|
| Cash flows from financing activities: |
|
|
|
|
| Payment for noncontrolling interest |
|
|
|
0
|
| Payments of contingent consideration |
|
|
0
|
|
| Proceeds from Issuance of Common Stock |
|
|
0
|
|
| Proceeds from Issuance of Preferred Stock and Preference Stock |
|
|
0
|
|
| Payments of Stock Issuance Costs |
|
|
0
|
|
| Payments of Ordinary Dividends, Preferred Stock and Preference Stock |
|
|
0
|
|
| Payments Related to Tax Withholding for Share-based Compensation |
|
|
0
|
0
|
| Excess tax benefit from stock-based compensation |
|
|
|
0
|
| Intercompany advances, net |
|
|
0
|
0
|
| Net cash used in financing activities |
|
|
0
|
0
|
| Net increase (decrease) in cash and cash equivalents |
|
|
0
|
0
|
| Cash and cash equivalents, beginning of year |
|
|
0
|
0
|
| Cash and cash equivalents, end of period |
$ 0
|
$ 0
|
$ 0
|
$ 0
|